Elanco Animal Health Incorporated ELAN
22.31
(0.04)
(0.18%)
as of 25 Sep
- Market cap
- $11.2B
- P/E
- 0.0×
Follow ELAN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.54% | (3.67%) | (3.77%) | (2.98%) | |
| 0.27% | (1.79%) | (1.85%) | (1.46%) | ||
ROIC |
1.21% | 0.09% | 0.35% | 0.51% | |
Return on Tangible Assets |
1.05% | (7.09%) | (7.30%) | (5.93%) | |
Average Days of Receivables |
77.52 | 72.77 | 86.08 | 83.76 | |
Free Cash Flow per Share |
0.74 | 0.57 | 0.63 | 0.76 | |
Free Cash Flow |
368.00 | 284.00 | 315.00 | 379.00 | |
Capital Expenditures |
(261.00) | (276.00) | (262.00) | (238.00) | |
Piotroski F-Score |
6.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
5.58% | 5.04% | 5.28% | 5.59% | |
Accounts Receivable Turnover |
4.89 | 5.16 | 4.42 | 4.45 | |
Accounts Payable Turnover |
6.77 | 6.39 | 6.27 | 5.64 | |
Inventory Turnover |
1.24 | 1.28 | 1.33 | 1.30 | |
Average Days of Payables |
62.13 | 63.30 | 61.75 | 69.55 | |
Days of Inventory on Hand |
301.46 | 298.78 | 285.00 | 288.12 | |
Tax Rate |
(3.25) | 0.04 | 0.23 | 0.20 | |
Research and Development Expense of Revenue |
7.75% | 7.80% | 7.58% | 7.39% | |
Selling, General and Administrative Expense of Revenue |
30.32% | 30.33% | 30.04% | 30.26% | |
Share Based Compensation of Revenue |
1.46% | 1.44% | 1.51% | 1.47% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
17.47 | (2.41) | (2.38) | (3.10) | |
Depreciation/Fixed assets |
0.48 | 0.48 | 0.50 | 0.49 | |
Capex/Depreciation |
(0.39) | (0.41) | (0.38) | (0.34) | |
Revenue per Share |
9.24 | 9.50 | 9.83 | 10.05 | |
Operating CF per Share |
1.27 | 1.13 | 1.16 | 1.24 | |
Capex per Share |
(0.53) | (0.56) | (0.53) | (0.48) | |
Capex to Sales |
0.06 | 0.06 | 0.05 | 0.05 | |
Net Profit Margin |
0.78% | (4.92%) | (4.95%) | (3.96%) |
Columns are period end dates